Edwards Lifesciences (EW)

EBITDA Growth

-11.24%

TTM · Period ending:

EW logo

EW EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-11.24%
EW TTM EBITDA YoY % (-37.69% → -11.24%)
High-resolution chart · PNG

EW ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Edwards Lifesciences EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-11.2382%
-21.4681%
-20.4187%
4.3989%
7.1441%
16.7753%
11.1224%
0.2644%
-1.0758%
-17.1984%
-17.5842%
-8.806%
-7.0035%
-1.1569%
3.5191%
0.0823%
1.2254%
78.6355%
79.7992%
86.9387%
96.5036%
-21.6372%
-19.0833%
3.0751%
2.0191%
56.7339%
50.7074%
-18.8352%
-20.9943%
-20.4059%
-24.8078%
16.1486%
15.769%
14.3822%
31.7705%
23.7426%
24.626%
26.9184%
19.6139%
17.8898%
18.267%
17.9435%
26.4161%
32.8378%
34.1379%
26.9246%
8.6511%
-2.2273%
-4.4574%
3.9383%
14.2636%
33.1156%
42.6202%
39.1014%
31.1865%
14.8961%
2.1457%
-0.4903%
5.4451%
8.9308%
1.7231%
0.3183%
-10.6342%
-3.9855%
24.8924%
28.6672%
67.1083%
40.6369%
22.2807%
21.6486%
-4.2013%
3.6988%
-1.0846%
-3.8328%
-9.2534%
-11.185%
-9.8905%
-10.3475%
8.4877%
13.695%
15.5375%
19.2272%
19.209%
17.7487%
20.1954%
24.1618%
7.7476%
11.0465%
89.117%
80.7732%
95.3514%
90.899%
-37.2827%
22.2222%
14.1975%
-11.6667%
44.7344%
-55.1546%
-54.3147%
-37.6909%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.